focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Non-Standard Finance (NSF): Reading the runes: strong, controlled growth

5 Dec 2018 14:23

Hardman & Co Research Hardman & Co Research: Non-Standard Finance (NSF): Reading the runes: strong, controlled growth 05-Dec-2018 / 14:22 GMT/BST


Hardman & Co Research: Reading the runes: strong, controlled growth

On 3 December, NSF held an investor day at the Reading branch of Everyday Loans (EL) and its head office in Bourne End. Investors and analysts thus got the opportunity to see the front-line operations and review the company's strategy. The former confirmed our view on the competitive advantages of a branch network and the operational synergies from being part of a group. The presentation confirmed the long-term, controlled growth opportunity from a business with an excellent market positioning and sustainable competitive advantages. We have not changed our forecasts following the update, and our absolute valuation range remains 91-101p. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/reading-the-runes-strong-controlled-growth/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Mark Thomas +44 20 7194 7622 mt@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

754839 05-Dec-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
11th Mar 20222:00 pmRNSShareholder Update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20213:56 pmRNSDirector/PDMR Shareholding
17th Dec 20213:52 pmRNSResults of General Meeting
2nd Dec 20217:00 amRNSAppointment of financial adviser and broker
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20214:06 pmRNSDirector/PDMR Shareholding
28th Sep 20214:37 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSUnaudited Half Year Results to 30 June 2021
24th Sep 20212:48 pmRNSPublication of 2021 half year results
10th Sep 20214:35 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSDirectorate Change
27th Aug 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSHolding(s) in Company - Correction
23rd Aug 20211:31 pmRNSHolding(s) in Company
23rd Aug 20211:30 pmRNSHolding(s) in Company
18th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20214:54 pmRNSResults of General Meeting
6th Aug 20214:41 pmRNSSecond Price Monitoring Extn
6th Aug 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:47 pmRNSDirector/PDMR Shareholding
30th Jun 20212:09 pmRNSResult of AGM
30th Jun 20218:54 amRNSAudited full year results to 31 December 2020
30th Jun 20217:02 amRNSAudited full year results to 31 December 2020
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSNotification of results and trading update
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Mar 20213:37 pmRNSPurchase of shares - Non-Executive Director fees
23rd Feb 20217:00 amRNSTrading Update
8th Jan 20214:41 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
5th Nov 202012:05 pmEQSHardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
2nd Nov 20203:56 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSUnaudited Half Year Results to 30 June 2020
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 202010:06 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.